The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents

被引：0
|
作者：
Carlos Zamora Atenza
Geòrgia Anguera
Mariona Riudavets Melià
Letícia Alserawan De Lamo
Ivana Sullivan
Andrés Barba Joaquin
Jorgina Serra Lopez
M. Angels Ortiz
Maria Mulet
Sílvia Vidal
Margarita Majem
机构：
[1] Biomedical Research Institut Sant Pau (IIB Sant Pau),Group of Immunology
[2] Hospital de La Santa Creu I San Pau. C,Inflammatory Diseases
[3] Universitat Autónoma de Barcelona (UAB),Department of Medical Oncology
[4] Institut Gustave Roussy,Department of Medicine
[5] Hospital de La Santa Creu I Sant Pau,Department of Medical Oncology
来源：
Cancer Immunology, Immunotherapy | 2022年 / 71卷
关键词：
Immunotherapy; NSCLC; Systemic PD-L1; Soluble PD-L1; Predictive biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1823 / 1835
页数：12
相关论文
共 50 条
  • [1] The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents
    Zamora Atenza, Carlos
    Anguera, Georgia
    Riudavets Melia, Mariona
    Alserawan De Lamo, Leticia
    Sullivan, Ivana
    Barba Joaquin, Andres
    Serra Lopez, Jorgina
    Angels Ortiz, M.
    Mulet, Maria
    Vidal, Silvia
    Majem, Margarita
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (08) : 1823 - 1835
  • [2] Integration of Systemic / Tumor PD-L1 as a Predictive Biomarker of Clinical Outcome in Advanced NSCLC Patients Treated With Anti-PD-(L)1 Agents
    Anguera Palacios, G.
    Zamora Atenza, C.
    Riudavets Melia, M.
    Alserawan De Lamo, L.
    Sullivan, I.
    Barba Joaquin, A.
    Serra Lopez, J.
    Ortiz, M. A.
    Mulet, M.
    Vidal Alcorisa, S.
    Majem, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1136 - S1137
  • [3] PD-L1 copy number gains: a predictive biomarker for PD-1/PD-L1 blockade therapy?
    Inoue, Yusuke
    Osman, Murat
    Suda, Takafumi
    Sugimura, Haruhiko
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S199 - S202
  • [4] ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors
    Wei Nie
    Zhi-Jie Wang
    Kai Zhang
    Bing Li
    Yi-Ran Cai
    Feng-Cai Wen
    Ding Zhang
    Yue-Zong Bai
    Xue-Yan Zhang
    Shu-Yuan Wang
    Lei Cheng
    Hua Zhong
    Li Liu
    Jie Wang
    Bao-Hui Han
    [J]. BMC Medicine, 20
  • [5] ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors
    Nie, Wei
    Wang, Zhi-Jie
    Zhang, Kai
    Li, Bing
    Cai, Yi-Ran
    Wen, Feng-Cai
    Zhang, Ding
    Bai, Yue-Zong
    Zhang, Xue-Yan
    Wang, Shu-Yuan
    Cheng, Lei
    Zhong, Hua
    Liu, Li
    Wang, Jie
    Han, Bao-Hui
    [J]. BMC MEDICINE, 2022, 20 (01)
  • [6] PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis
    Passiglia, Francesco
    Bronte, Giuseppe
    Bazan, Viviana
    Natoli, Clara
    Rizzo, Sergio
    Galvano, Antonio
    Listi, Angela
    Cicero, Giuseppe
    Rolfo, Christian
    Santini, Daniele
    Russo, Antonio
    [J]. ONCOTARGET, 2016, 7 (15) : 19738 - 19747
  • [7] PD-L1 Expression as Predictive Biomarker in Patients with NSCLC: A Pooled Analysis
    Passiglia, Francesco
    Bronte, Giuseppe
    Rizzo, Sergio
    Galvano, Antonio
    Sortino, Giovanni
    Musso, Emmanuela
    Listi, Angela
    Barraco, Nadia
    Castiglia, Marta
    Calo, Valentina
    Bazan, Viviana
    Cicero, Giuseppe
    Rolfo, Christian
    Russo, Antonio
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S232 - S233
  • [8] Predictive factors of response to PD-(L)1 inhibitors in patients with advanced non-small cell lung (NSCLC) and high PD-L1 expression
    Barba Joaquin, A.
    Piedra, A.
    Mosquera, J.
    Riudavets, M.
    Gomez-Randulfe, M. I.
    Garcia Campelo, M. R.
    Sullivan, I. G.
    Serra, J.
    Aguado, M.
    Majem Tarruella, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S768 - S769
  • [9] PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
    Bocanegra, Ana
    Fernandez-Hinojal, Gonzalo
    Zuazo-Ibarra, Miren
    Arasanz, Hugo
    Jesus Garcia-Granda, Maria
    Hernandez, Carlos
    Ibanez, Maria
    Hernandez-Marin, Berta
    Martinez-Aguillo, Maite
    Jose Lecumberri, Maria
    Fernandez de Lascoiti, Angela
    Teijeira, Lucia
    Morilla, Idoia
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07):
  • [10] Relevance of host and tumor PD-L1 in PD-L1 pathway blockade
    Kryczek, Ilona
    Lin, Heng
    Wei, Shuang
    Green, Michael
    Zou, Weiping
    [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
12345